The trial focused on a drug called Duavee, a combination of conjugated estrogens and bazedoxifene, which is already approved ...

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new ...

Lobular breast cancer is more common than ovarian or skin cancer but there is little awareness around it, despite it being ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

"There’s an alchemy that takes place in gratitude, acceptance, meditation, and the frequency of love. It makes a difference." ...

Cancer patients and doctors in Ontario are advocating for scalp cooling treatments to be covered by OHIP to provide increased ...

Compared with digital mammography, 3D mammography (or tomosynthesis) reduces recall rates and improves specificity in women ...

Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help ...

In the CheckMate 274 study, adjuvant nivolumab demonstrated a significant improvement in disease-free survival (DFS) and showed a trend toward improved overall survival (OS) in an unselected ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

Artificial intelligence can now help doctors determine which pancreatic cysts are harmless and which are potentially ...